This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA.Weight loss injections have become incredibly popular in the ...

As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...

Tom Nolan reviews this week’s research Giving a hearing aid to people with untreated hearing loss helps them retain one additional person in their social network over a three year period. This catchy ...

Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

Incretin mimetics are revolutionizing obesity treatment, but high prices and supply shortages limit patient access. Some clinicians have suggested less frequent dosing as an off-ramping strategy to ...

Wilde is getting more, and better, sleep now that his sleep apnea is under control, thanks to his CPAP machine and tirzepatide. Also known as Zepbound or Mounjaro, it's the same drug helping millions ...

The FDA has approved medications like Zepbound and Wegovy for weight loss, which use the same active ingredient as the ...

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.